1. "Mark Robson"
  2. "Maura Dickler"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (10)
Groups
  1. Breast Medicine Service (23)
  2. Department of Medicine (23)
  3. Population Sciences Research Program (23)
  4. Solid Tumor Oncology Division (23)
  5. Survivorship Research (23)
  6. Epidemiology and Biostatistics (19)

More Groups

People
  1. Mark Robson (23)
  2. Maura Dickler (23)
  3. Clifford Hudis (17)
  4. Larry Norton (13)
  5. Chau Dang (11)
  6. Diana Lake (10)

More People

Years
  1. 2020 (2)
  2. 2019 (1)
  3. 2018 (3)
  4. 2017 (1)
  5. 2016 (1)
  6. 2015 (3)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer Research (4)
  3. Breast Cancer Research and Treatment (3)
  4. Clinical Cancer Research (2)
  5. Cancer (1)
  6. Cancer Cell (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. American Society of Clinical Oncology (5)
  3. Springer (3)
  4. Elsevier Inc. (2)
  5. American Association for the Advancement of Science (1)
  6. American Medical Association (1)

More Publishers

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors
    Journal Article

    Razavi, P.; Dickler, M. N.; Shah, P. D.; Toy, W.; Brown, D. N.; Won, H. H.; Li, B. T.; Shen, R.; Vasan, N.; Modi, S.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency
    Journal Article

    Oktay, K. H.; Bedoschi, G.; Goldfarb, S. B.; Taylan, E.; Titus, S.; Palomaki, G. E.; Cigler, T.; Robson, M.; Dickler, M. N.
    Fertility and Sterility (2020)

    Fulltext@MSK | Save
  • Impact of BRCA mutations on chemotherapy-induced loss of ovarian reserve: A prospective longitudinal study
    Meeting Abstract

    Oktay, K.; Bedoschi, G.; Goldfarb, S. B.; Taylan, E.; Titus, S.; Palomaki, G. E.; Cigler, T.; Robson, M.; Dickler, M. N.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients
    Meeting Abstract

    Bao, T.; Seidman, A. D.; Piulson, L.; Chen, X.; Vickers, A. J.; Vertosick, E.; Blinder, V. S.; Zhi, W. I.; Li, Q. S.; Vahdat, L. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant advanced breast cancers
    Journal Article

    Razavi, P.; Chang, M. T.; Xu, G.; Bandlamudi, C.; Ross, D. S.; Vasan, N.; Cai, Y.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients
    Journal Article

    Bao, T.; Seidman, A. D.; Piulson, L.; Vertosick, E.; Chen, X.; Vickers, A. J.; Blinder, V. S.; Zhi, W. I.; Li, Q.; Vahdat, L. T.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Journal Article

    Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z. K.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A.; Walsh, M. F.; Li, Y.; more...
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save
  • Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status
    Journal Article

    Shah, P. D.; Patil, S.; Dickler, M. N.; Offit, K.; Hudis, C. A.; Robson, M. E.
    Cancer (2016)

    Fulltext@MSK | Save
  • Oncotype DX in BRCA-associated vs. sporadic breast cancers: Differences based on germline mutation status and potential implications for adjuvant systemic therapy (AST)
    Meeting Abstract

    Shah, P. D.; Patil, S.; Dickler, M. N.; Offit, K.; Hudis, C. A.; Robson, M. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The impact of adjuvant breast cancer (BC) chemotherapy on ovarian reserve and menses
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M. E.; Moy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save